Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Direxion Daily S&P Biotech Bull 3X Shares LABU

The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index (index). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds that track the index and other financial instruments that provide... see more

Opinion & Analysis (ARCA:LABU)

Energy Rebound Sparks Leveraged ETF Action

Benzinga.com  October 12, 2015

Leveraged ETF Rebalancing: It's Not As Bad As It Seems

Benzinga.com  October 6, 2015

Breaking Down Biotech ETFs With Leverage

Benzinga.com  October 2, 2015

Wild Ride For Leveraged Biotech ETFs Continues

Benzinga.com  September 28, 2015

ETF Outlook: More Biotech Blunders Or A Biotech Bounce?

Benzinga.com  September 27, 2015

Traders Bet Against Hillary With Leveraged Biotech ETF

Benzinga.com  September 23, 2015

Investors In This Biotech ETF Must Have Loved Hillary Clinton's Tweet

Benzinga.com  September 22, 2015

They're Heeere: Leveraged Cybersecurity ETFs

Benzinga.com  September 16, 2015

This May Get Ugly, ETF Investors

Benzinga.com  August 22, 2015

Oil Shock Is A Big Deal For This ETF And That's OK

Benzinga.com  August 21, 2015

The Other Bearish Biotech ETF Is Looking Groovy, Too

Benzinga.com  August 21, 2015

A Bad Sign For Biotech Bulls

Benzinga.com  August 20, 2015

4 New Leveraged ETFs Right For The Times

Benzinga.com  August 19, 2015

Dancing With The Devil: Looking For Bottoms With Leveraged Bull Energy ETFs

Benzinga.com  August 11, 2015

This Week's ETF's To Watch: A Lot Of Familiar Faces

Benzinga.com  August 9, 2015

A Bad Week For Biotech Was Great For This ETF

Benzinga.com  August 7, 2015

For The Bold: Bearish Energy ETF Ideas

Benzinga.com  August 5, 2015

Even With Recent Declines, Investors Still Love Biotech ETFs

Benzinga.com  July 30, 2015

A Big Day For Biotech And It's Not Going So Well

Benzinga.com  July 27, 2015

ProShares Releases 2 New Leveraged Biotech ETFs

Benzinga.com  June 23, 2015